Company profile · Biotech & medical
Synmosa Biopharma
健喬信元醫藥生技股份有限公司 · 4114
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Synmosa Biopharma manufactures and sells various drugs and medical devices, holding a total of 625 drug licenses including 409 domestic drug licenses, 39 import drug licenses, and 177 export licenses.[1]
The company also offers more than 550 cosmetics and functional food products, and engages in the wholesale, retail, and manufacturing of related pharmaceutical, food, cosmetic, and veterinary products.[2]
Its sales coverage extends across China, ASEAN countries including Singapore, Malaysia, Thailand, Vietnam, and the Philippines, South Africa, Mongolia, Central and South America, and Canada.[2]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$767m | +41.2% | +2.6% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$14m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | SYNMOSA BIOPHARMA CORPORATION |
|---|---|
| Chinese name | 健喬信元醫藥生技股份有限公司 |
| Stock code | 4114 (TPEx) |
| Industry | Biotech & medical |
| Founded | 25 Aug 1970 |
| Listed | 12 May 2003 |
| Paid-in capital | NT$5.5bn |
| Chairman | 林智暉 |
| President | 林智暉 |
| Headquarters | 11TH FL., NO.396, SEC. 1, NEIHU ROAD, TAIPEI, TAIWAN, R.O.C. |
| Website | http://www.synmosa.com.tw |
| Official business description | 各種藥品醫療器材製造販賣業務 · 各種化妝品動物藥品製造販賣業務 · 各種化學食品添加物及飲料製造販賣業務 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 健喬信元醫藥生技股份有限公司 · mops · retrieved 03 Nov 2026
- Annual report 2025 (English), business scope · annual_report · retrieved 03 Nov 2026
Using it at work? Join the team-plan waiting list